PUBH 6005 Week 11 Synthesis Paper Example

One Problem, Three Lenses: A Synthesis Paper Binding What the Readings Say, Where I Now Stand and How My Pharmacy Practice Will Change on Cost-Related Insulin Rationing

Student Name

Walden University

PUBH 6005: Perspectives on Health and the Developing Scholar-Practitioner

Instructor Name

Month Day, Year

One Problem, Three Lenses: A Synthesis Paper Binding What the Readings Say, Where I Now Stand and How My Pharmacy Practice Will Change on Cost-Related Insulin Rationing

Introduction

I began this course believing that insulin rationing was a problem I could solve one patient at a time. Eleven weeks later I hold a different position: rationing is a population pattern produced mainly by what people are asked to pay, and individual counseling, though still worth doing, works at the wrong level to change that pattern. This paper brings together what the readings showed, the position I now hold and what will change in my practice. It also names what I still do not know.

What the Readings Showed

The Problem Is Measured, and Common

Two studies anchor my understanding. At a single academic diabetes center, roughly 25% of 199 respondents described cutting back on insulin over its price (Herkert et al., 2019). Drawing on a nationally representative interview survey, Gaffney et al. (2022) put the share of US adults on insulin who rationed during the prior year at around 16%, about 1.3 million people. The figures differ because the populations differ, and keeping them apart was one of the first scholarly habits this course asked of me.

The Problem Has Conditions, Not Only Causes

A review of social determinants and diabetes describes how income, access to care, the food environment and neighborhood conditions shape who develops diabetes and how it progresses (Hill-Briggs et al., 2021). Rationing fits inside that account as a specific route by which income and coverage reach the body. The national survey's finding that rationing was more common among younger adults and the uninsured supports reading it as a pattern of exposure to cost rather than of individual motivation (Gaffney et al., 2022).

The Level of Response Matters

Rose (1985) separated the question of why some individuals fall ill from the question of why a population has a high rate, arguing that the second calls for strategies aimed at whole populations. Frieden (2010) turned a similar insight into a pyramid of interventions, with changes to people's context near the base, reaching many without depending on individual effort, and counseling near the top. Read together, they told me that a savings card handed across my counter and a cap on monthly insulin cost sharing are not two versions of the same solution. They operate at different levels and reach different numbers of people.

Evidence Has a Method

Brownson et al. (2009) describe evidence-based public health as combining the best available research with community knowledge and resources. Learning to search systematically, appraise a study's design and cite in a way a reader can follow were the practical skills behind that idea. My search log found a small, recent literature; my appraisal of the clinic survey showed how a narrow finding becomes a broad claim through careless citation.

Where I Now Stand

My position has three parts. First, cost-related insulin rationing should be treated as a public health problem, measured in populations and addressed through the conditions that produce it. Second, policies that limit what patients pay at the point of sale are the most promising responses, because they work for everyone covered without requiring each patient to find help. Third, whether such policies have actually reduced rationing is still an open question for me. The federal $35 monthly cap for Medicare Part D insulin and the state caps for some private plans are recent, and I have read the titles of studies examining them but not yet appraised their findings. I will not claim they work until I have.

How My Practice Will Change

At the Counter

I will ask about cost before adherence. When a patient's refill is late, my first question will be whether the price has changed, not whether they forgot. I will also track, informally at first, whether late refills cluster in the first months after deductibles start over.

In My Writing

Every claim about a population will carry its source and the population that source studied. My own observations will appear as examples and be labeled as mine. Where I have read only an abstract, I will say so. These habits came from the APA and integrity work in this course, and from the uncomfortable discovery that I had stretched a clinic finding into a national claim in my own first post.

In My Career

I plan to move toward medication access work in a health department or health plan, where I can contribute to the base of the pyramid rather than only its top. My professional goals plan names the skills I need: quantifying a problem, appraising evidence, understanding pricing and coverage policy and evaluating programs.

What I Still Do Not Know

Three questions remain. I do not know how common rationing is in Ohio, because I have not found a state estimate. I do not know whether rationing sends people to emergency departments or hospitals often enough for a health department to count. And I do not know whether the recent caps have changed the national pattern. These are the questions I want the rest of the program to help me answer.

The Scholar-Practitioner, Revisited

At the start of the course, scholar and practitioner felt like two jobs competing for my time. They now look like two halves of one way of working. My practice told me rationing existed before I had read a single study. The scholarly habits this course taught let me describe it in a way a stranger can check, place it within the conditions that produce it and judge responses by how many people they reach. The research on misconduct I read for the integrity memo suggests that small stretches of evidence are far more common than outright fabrication (Fanelli, 2009); a scholar-practitioner's discipline is mostly about refusing those small stretches.

Conclusion

Insulin rationing is common, measurable and shaped by cost. Responding to it well means working at the level of populations and conditions while keeping the patient at the counter in view. That combination is what I came to this program to learn, and this course has given me its first tools.

References

Brownson, R. C., Fielding, J. E., & Maylahn, C. M. (2009). Evidence-based public health: A fundamental concept for public health practice. Annual Review of Public Health, 30, 175-201. https://doi.org/10.1146/annurev.publhealth.031308.100134

Fanelli, D. (2009). How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS ONE, 4(5), e5738. https://doi.org/10.1371/journal.pone.0005738

Frieden, T. R. (2010). A framework for public health action: The health impact pyramid. American Journal of Public Health, 100(4), 590-595. https://doi.org/10.2105/AJPH.2009.185652

Gaffney, A., Himmelstein, D. U., & Woolhandler, S. (2022). Prevalence and correlates of patient rationing of insulin in the United States: A national survey. Annals of Internal Medicine, 175(11), 1623-1626. https://doi.org/10.7326/M22-2477

Herkert, D., Vijayakumar, P., Luo, J., Schwartz, J. I., Rabin, T. L., DeFilippo, E., & Lipska, K. J. (2019). Cost-related insulin underuse among patients with diabetes. JAMA Internal Medicine, 179(1), 112-114. https://doi.org/10.1001/jamainternmed.2018.5008

Hill-Briggs, F., Adler, N. E., Berkowitz, S. A., Chin, M. H., Gary-Webb, T. L., Navas-Acien, A., Thornton, P. L., & Haire-Joshu, D. (2021). Social determinants of health and diabetes: A scientific review. Diabetes Care, 44(1), 258-279. https://doi.org/10.2337/dci20-0053

Rose, G. (1985). Sick individuals and sick populations. International Journal of Epidemiology, 14(1), 32-38. https://doi.org/10.1093/ije/14.1.32